The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study
Open accessAbstract
Objective To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, double-blind, randomized, sham-controlled trial. Methods A total of 248 participants with episodic migraine with/without aura were randomized to receive nVNS or sham within 20 minutes from pain onset. Participants were to repeat treatment if pain had not improved in 15 minutes. Results nVNS (n = 120) was superior to sham (n = 123) for pain freedom at 30 minutes (12.7% vs 4.2%; p = 0.012) and 60 minutes (21.0% vs 10.0%; p = 0.023) but not at 120 minutes (30.4% vs 19.7%; p = 0.067; primary endpoint; logistic regression) after the first treated attack. A post hoc repeated-measures test provided further insight into the therapeutic benefit of nVNS through 30, 60, and 120 minutes (odds ratio 2.3; 95% confidence interval 1.2, 4.4; p = 0.012). nVNS demonstrated benefits across other endpoints including pain relief at 120 minutes and was safe and well-tolerated. Conclusion This randomized sham-controlled trial supports the abortive efficacy of nVNS as early as 30 minutes and up to 60 minutes after an attack. Findings also suggest effective pain relief, tolerability, and practicality of nVNS for the acute treatment of episodic migraine. ClinicalTrials.gov identifier NCT02686034. Classification of evidence This study provides Class I evidence that for patients with an episodic migraine, nVNS significantly increases the probability of having mild pain or being pain-free 2 hours poststimulation (absolute difference 13.2%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To date, only a few small studies have assessed and found the practice of mindfulness beneficial for acute treatment of migraine.42, 43”
From Mechanisms of mindfulness in patients with migraine: Results of a qualitative study. (2023) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Ferrari, M. D., Roon, K. I., Lipton, R. B., & Goadsby, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06711-3 · Cited by 987
Bigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 845
Ferrari, M., Goadsby, P., Roon, K., & Lipton, R. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00404.x · Cited by 605
Marmura, M. J., Silberstein, S. D., & Schwedt, T. J. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12499 · Cited by 568
Lipton, R. B., Dodick, D. W., Silberstein, S. D., Saper, J. R., Aurora, S. K., Pearlman, S. H., Fischell, R. E., Ruppel, P. L., & Goadsby, P. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70054-5 · Cited by 465
How Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
International Headache Society Clinical Trials Subcommittee members:, Tfelt-Hansen, P., Pascual, J., Ramadan, N., Dahlöf, C., D'Amico, D., Diener, H.-C., Hansen, J. M., Lanteri-Minet, M., Loder, E., et al. (2012) · Cephalalgia · doi:10.1177/0333102411417901 · Cited by 365
Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial
Schoenen, J., Vandersmissen, B., Jeangette, S., Herroelen, L., Vandenheede, M., Gérard, P., & Magis, D. (2013) · Neurology · doi:10.1212/wnl.0b013e3182825055 · Cited by 360
Gaul, C., Diener, H.-C., Silver, N., Magis, D., Reuter, U., Andersson, A., Liebler, E. J., Straube, A., & on behalf of the PREVA Study Group (2016) · Cephalalgia · doi:10.1177/0333102415607070 · Cited by 279
Self-citation
Cited by
Ailani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
“Neuromodulatory devices can also be considered (electrical trigeminal nerve stimulation [eTNS] 53,54 ; noninvasive vagus nerve stimulation [nVNS] 44 ; remote electrical neuromodulation [REN] 45,46 ; or single-pulse transcranial magnetic stimulation [sTMS] 42 ).”
BackgroundMethodFerrari, M. D., Goadsby, P. J., Burstein, R., Kurth, T., Ayata, C., Charles, A., Ashina, M., van den Maagdenberg, A. M. J. M., & Dodick, D. W. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00328-4 · Cited by 500
Ashina, S., Terwindt, G. M., Steiner, T. J., Lee, M. J., Porreca, F., Tassorelli, C., Schwedt, T. J., Jensen, R. H., Diener, H.-C., & Lipton, R. B. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00415-0 · Cited by 213
Self-citationVagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms
Wang, Y., Zhan, G., Cai, Z., Jiao, B., Zhao, Y., Li, S., & Luo, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.018 · Cited by 206
Hallmarks of primary headache: part 1 – migraine
Raggi, A., Leonardi, M., Arruda, M., Caponnetto, V., Castaldo, M., Coppola, G., Della Pietra, A., Fan, X., Garcia-Azorin, D., Gazerani, P., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01889-x · Cited by 198
“…migraine whereas a meta-analysis published in 2023 reported the effectiveness of VNS in EM and encouraging results in the management of CM (in terms of monthly reduced headache days, pain-free rates, ≥ 50% responder rate, headache intensity and monthly acute medication reduction days) [300–302].”
Self-citation
Metadata
- Authors
- Tassorelli, C., Grazzi, L., de Tommaso, M., Pierangeli, G., Martelletti, P., Rainero, I., Dorlas, S., Geppetti, P., Ambrosini, A., Sarchielli, P., Liebler, E., Barbanti, P., On behalf of the PRESTO Study Group, PRESTO Study Group, Tassorelli, C., Bitetto, V., De Icco, R., Martinelli, D., Sances, G., Bianchi, M., Grazzi, L., Padovan, A. M., de Tommaso, M., Ricci, K., Vecchio, E., Cortelli, P., Cevoli, S., Pierangeli, G., Terlizzi, R., Martelletti, P., Negro, A., Chiariello, G. A., Rainero, I., De Martino, P., Gai, A., Govone, F., Masuzzo, F., Rubino, E., Torrieri, M. C., Vacca, A., Geppetti, P., Chiarugi, A., De Cesaris, F., Puma, S. L., Lupi, C., Marone, I., Ambrosini, A., Perrotta, A., Sarchielli, P., Bernetti, L., Corbelli, I., Romoli, M., Simoni, S., Verzina, A., Barbanti, P., Aurilia, C., Egeo, G., Fofi, L., Liebler, E., Andersson, A., Spitzer, L., Marin, J., McClure, C., Thackerey, L., Baldi, M. G., & Di Maro, D.
- Affiliations
- University of Pavia (IT)
- ORCID
- Bitetto, Vito
- Martinelli, Daniele
- Sances, Grazia
- Bianchi, Monica
- Ricci, Katia
- Vecchio, Eleonora
- Cortelli, Pietro
- Cevoli, Sabina
- Negro, Andrea
- Gai, Annalisa
- Rubino, Elisa
- Torrieri, Maria Claudia
- Vacca, Alessandro
- Chiarugi, Alberto
- Puma, Simone Li
- Lupi, Chiara
- Perrotta, Armando
- Bernetti, Laura
- Corbelli, Ilenia
- Romoli, Michele
- Simoni, Simone
- Verzina, Angela
- Aurilia, Cinzia
- Egeo, Gabriella
- Fofi, Luisa
- McClure, Candace
- Venue
- Neurology
- Published
- 2018-07-24
- Volume
- 91
- Issue
- 4
- Pages
- e364-e373
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6070381
- OpenAlex
- W2808133247
- Cited by
- 254
- References
- 36
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 27 · 2023: 28 · 2022: 27 · 2021: 36 · 2020: 39 · 2019: 39 · 2018: 12
- FWCI
- 24.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Neurology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by-nc-nd)
- Funders
- Abbott Laboratories
- Amgen
- Eli Lilly and Company
- Pfizer
- Novartis
- Sanofi
- Teva Pharmaceutical Industries
- Chiesi Farmaceutici
- Mylan
- TauRx Pharmaceuticals
- European Commission (HORIZON2020)
- Ministero della Salute
- Almirall
- Allergan
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- non-invasive vagus nerve stimulation, migraine, acute migraine treatment, abortive treatment, episodic migraine, migraine with aura, analgesia, tolerability, safety
- MeSH terms
- Adult, Double-Blind Method, Female, Humans, Male, Middle Aged, Migraine Disorders, Pain Measurement, Prospective Studies, Treatment Outcome, Vagus Nerve Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study. https://app.cochat.ai/papers/10.1212/wnl.0000000000005857
- The paper
- Tassorelli, C., Grazzi, L., de Tommaso, M., Pierangeli, G., Martelletti, P., Rainero, I., Dorlas, S., Geppetti, P., Ambrosini, A., Sarchielli, P., Liebler, E., Barbanti, P., On behalf of the PRESTO Study Group, PRESTO Study Group, Tassorelli, C., Bitetto, V., De Icco, R., Martinelli, D., Sances, G., . . . Di Maro, D. (2018). Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study. Neurology. https://doi.org/10.1212/wnl.0000000000005857
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.